Management of a drug-drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma

AIDS. 2023 Jun 1;37(7):1181-1183. doi: 10.1097/QAD.0000000000003527.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Craniopharyngioma* / complications
  • Craniopharyngioma* / drug therapy
  • Drug Interactions
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Pituitary Neoplasms* / complications
  • Pituitary Neoplasms* / drug therapy
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors

Substances

  • Anti-HIV Agents
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf